Trice Medical
Malvern, US · Founded 2011 · Delaware corporation
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$123.2M disclosed across 9 rounds · 2012–2023
▶$10.5MraisedAug 2023 · 2 investors · Other Health CareRule 506(b)
- NIMESH SHAHDirector
- CHAD NORMANDirector
- MICHAEL STEENExecutive Officer, Director
- Offering amount
- $17.5M
- Amount sold
- $10.5M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedOct 2022 · 209 investors · Other Health CareRule 506(b)
- ALAN DAVISDirector
- ERIC C. SALZMANDirector
- MICHAEL SCHRAUBENDirector
- MARK FOSTERExecutive Officer, Director
- VASANT PADMANABHANDirector
- CHRIS YAMAMOTODirector
- RANDY SCOTTDirector
- Offering amount
- $7.3M
- Amount sold
- $7.3M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.6MraisedSep 2021 · 39 investors · Other Health CareRule 506(b)
- Michael SchraubenDirector
- Randy ScottDirector
- Mark FosterExecutive Officer, Director
- Alan DavisDirector
- Gary KurtzmanDirector
- Vasant PadmanabhanDirector
- Chris YamamotoDirector
- Offering amount
- $37.6M
- Amount sold
- $27.6M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.2MraisedApr 2021 · 22 investors · Other Health CareRule 506(b)
- Alan DavisDirector
- Randy ScottDirector
- Mark FosterExecutive Officer, Director
- Vasant PadmanabhanDirector
- Gary KurtzmanDirector
- Michael SchraubenDirector
- Offering amount
- $11M
- Amount sold
- $10.2M
- Minimum investment
- $1
- Proceeds to insiders
- $500K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedMar 2020 · 8 investors · Other Health CareRule 506(b)
- Alan DavisDirector
- Randy ScottDirector
- Vasant PadmanabhanDirector
- Michael SchraubenDirector
- Craig K. CarraExecutive Officer
- Gary KurtzmanDirector
- Mark FosterExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $2.1M
- Minimum investment
- $1
- Proceeds to insiders
- $700K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.6MraisedJan 2019 · 47 investors · Other Health CareRule 506(b)
- William A. HawkinsDirector
- Randy ScottDirector
- Mark FosterExecutive Officer
- Vasant PadmanabhanDirector
- Gary KurtzmanDirector
- Mark SchraubonDirector
- Alan DavisDirector
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Craig CarraExecutive Officer
- Offering amount
- $42.3M
- Amount sold
- $40.6M
- Minimum investment
- $1
- Finders' fees
- $250K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedDec 2016 · 5 investors · Other Health CareRule 506(b)
- Richard WashburnExecutive Officer
- Gary KurtzmanDirector
- Craig CarraExecutive Officer
- William A. HawkinsDirector
- Steve AlmanyDirector
- Garheng KongDirector
- Jeffrey F. O'DonnellExecutive Officer, Director
- Mark FosterExecutive Officer
- Offering amount
- $6.3M
- Amount sold
- $5M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.1MraisedJan 2015 · 30 investors · Other Health CareRule 506(b)
- Richard KienzleDirector
- Richard WashburnExecutive Officer
- Garheng KongDirector
- Jeffrey O'DonnellExecutive Officer, Director
- Craig CarraExecutive Officer
- Steve AlmanyDirector
- Gary KurtzmanDirector
- Offering amount
- $18.1M
- Amount sold
- $18.1M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCompanies competing with Trice Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Trice Medical do?
- Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
- How much funding has Trice Medical raised?
- Trice Medical has disclosed $123.2M raised across 9 rounds.
- Where is Trice Medical headquartered?
- Trice Medical is headquartered in Malvern, US.